Singapore markets closed

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.24-0.56 (-4.38%)
At close: 04:00PM EDT
12.00 -0.24 (-1.96%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.32B
Enterprise value 1.00B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.56
Price/book (mrq)3.63
Enterprise value/revenue 1.97
Enterprise value/EBITDA -5.65

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-81.44%
S&P500 52-week change 323.10%
52-week high 383.60
52-week low 310.87
50-day moving average 314.29
200-day moving average 317.40

Share statistics

Avg vol (3-month) 31.28M
Avg vol (10-day) 31.06M
Shares outstanding 5107.61M
Implied shares outstanding 6108.57M
Float 897.55M
% held by insiders 19.26%
% held by institutions 194.33%
Shares short (15 Apr 2024) 46.04M
Short ratio (15 Apr 2024) 43.46
Short % of float (15 Apr 2024) 46.71%
Short % of shares outstanding (15 Apr 2024) 45.61%
Shares short (prior month 15 Mar 2024) 45.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -40.65%
Operating margin (ttm)-33.64%

Management effectiveness

Return on assets (ttm)-12.09%
Return on equity (ttm)-51.53%

Income statement

Revenue (ttm)509.34M
Revenue per share (ttm)4.79
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)N/A
EBITDA -216.46M
Net income avi to common (ttm)-207.04M
Diluted EPS (ttm)-1.95
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)910.62M
Total cash per share (mrq)8.5
Total debt (mrq)604.47M
Total debt/equity (mrq)166.75%
Current ratio (mrq)5.78
Book value per share (mrq)3.38

Cash flow statement

Operating cash flow (ttm)-73.34M
Levered free cash flow (ttm)-10.2M